Among patients with COPD, those receiving 6-week nicotinamide riboside, “a B3-like vitamin,” had significantly decreased lung ...

This study documents that anemia occurs relatively frequently in COPD patients and is related to the presence of inflammation. Anemia is an understudied issue in COPD but may be of great ...

People in rural areas are at greater risk of developing chronic obstructive pulmonary disease (COPD) due to a variety of factors. We explain why.

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...

Steroids are among the medications commonly prescribed to treat COPD. They help reduce the inflammation in your lungs caused by flare-ups. Steroids come in oral and inhaled forms. There are also ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

The following is a summary of “NTHi killing activity is reduced in COPD patients and is associated with a differential ...

Columnist Caroline Gainer discusses a study whose findings suggested that respiratory muscle strength training could help ...

Biologic drugs are designed to target specific parts of the immune system that contribute to chronic inflammatory diseases like COPD. According to Sanofi, the maker of Dupixent, it is the first ...

Researchers have found in a phase 3 trials that Dupilumab significantly reduced moderate or severe COPD exacerbations ...